Publications
1. Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR [2021]
2. Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells [2021]
3. Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies [2020]
4. Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy [2020]
6. Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch [2019]
8. Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia [2018]
9. Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells [2017]
10. A compound chimeric antigen receptor strategy for targeting multiple myeloma [2017]
11. Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor [2017]
12. Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies [2016]